CILOSTAZOL TREATMENT IN PATIENTS SUFFERING FROM INTERMITTENT CLAUDICATION ASSOCIATED WITH BUERGER'S DISEASE

被引：0
|
作者：
Kaya, E. [1 ]
Doganci, S. [1 ]
Arslan, G. [1 ]
Karabacak, K. [1 ]
Bolcal, C. [1 ]
机构：
[1] Gulhane Mil Med Acad, Dept Cardiovasc Surg, Ankara, Turkey
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 163卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [31] Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication
    Stevens, J. W.
    Simpson, E.
    Harnan, S.
    Squires, H.
    Meng, Y.
    Thomas, S.
    Michaels, J.
    Stansby, G.
    BRITISH JOURNAL OF SURGERY, 2012, 99 (12) : 1630 - 1638
  • [32] Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK
    Guest, JF
    Davie, AM
    Clegg, JP
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (06) : 817 - 826
  • [33] ASSOCIATION OF CILOSTAZOL USE WITH LONG TERM VASCULAR OUTCOMES IN PATIENTS WITH INTERMITTENT CLAUDICATION
    Muncan, Brandon
    Abboud, Alan
    Tassiopoulos, Apostolos K.
    Kalogeropoulos, Andreas P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1767 - 1767
  • [34] Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication
    Elam, MB
    Heckman, J
    Crouse, JR
    Hunninghake, DB
    Herd, JA
    Davidson, M
    Gordon, IL
    Bortey, EB
    Forbes, WP
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) : 1942 - 1947
  • [35] Cost-Effectiveness of Cilostazol, Naftidrofuryl Oxalate, and Pentoxifylline for the Treatment of Intermittent Claudication in People With Peripheral Arterial Disease
    Meng, Yang
    Squires, Hazel
    Stevens, John W.
    Simpson, Emma
    Harnan, Sue
    Thomas, Steve
    Michaels, Jonathan
    Stansby, Gerard
    O'Donnell, Mark E.
    ANGIOLOGY, 2014, 65 (03) : 190 - 197
  • [36] Conservative treatment for patients with intermittent claudication
    Sugimoto, I.
    Ohta, T.
    Ishibashi, H.
    Iwata, H.
    Yamada, T.
    Tadakoshi, M.
    Hida, N.
    Orimoto, Y.
    INTERNATIONAL ANGIOLOGY, 2010, 29 (02) : 55 - 60
  • [37] Differential scanning calorimetric evaluation of the human plasma in patients using cilostazol for the treatment of intermittent claudication (a preliminary study)
    Benko, Laszlo
    Fazekas, Gabor
    Szabo, Dorottya
    Lorinczy, Denes
    JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2024, 149 (11) : 5251 - 5255
  • [38] Outcomes of endovascular treatment of patients with intermittent claudication due to femoropopliteal disease
    Naiem, Ahmed A.
    Doonan, Robert James
    Steinmetz, Oren K.
    MacKenzie, Kent S.
    Girsowicz, Elie
    Bayne, Jason P.
    Obrand, Daniel, I
    Gill, Heather L.
    VASCULAR, 2022, 30 (05) : 882 - 890
  • [39] Cilostazol Pharmacokinetics after Single and Multiple Oral Doses in Healthy Males and Patients with Intermittent Claudication Resulting from Peripheral Arterial Disease
    Steven L. Bramer
    William P. Forbes
    Suresh Mallikaarjun
    Clinical Pharmacokinetics, 1999, 37 : 1 - 11
  • [40] Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease
    Bramer, SL
    Forbes, WP
    Mallikaarjun, S
    CLINICAL PHARMACOKINETICS, 1999, 37 (Suppl 2) : 1 - 11
12345